The translation of P-gp is downregulated by estrogen in estrogen receptor–positive (ER-positive) breast cancer cell lines without affecting estrogen receptor–negative (ER-negative) breast cancer cell lines or DOX-resistant ER-negative ovarian cancer cell lines (264, 265). Here, ESR1 is linked to breast carcinoma.